Emosis Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Liquidation

Emosis General Information

Description

Operator of a medical technology company intended for cardiovascular and cerebrovascular diseases. The company specializes in the development and commercialization of in vitro diagnostic tests for hemostasis abnormalities that cause hemorrhagic or thromboembolic manifestations, enabling patients to get neurovascular diseases, cancer, pregnancy, and pharmacological and non-pharmacological therapy management.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 11 rue de l'Industrie
  • 67400 Illkirch-Graffenstaden
  • France
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 11 rue de l'Industrie
  • 67400 Illkirch-Graffenstaden
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emosis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Bankruptcy: Liquidation 06-Jun-2023 Completed Bankruptcy: Liquidation
8. Accelerator/Incubator Completed Generating Revenue
7. Later Stage VC 29-Sep-2022 Completed Generating Revenue
6. Later Stage VC 12-May-2020 Completed Generating Revenue
5. Later Stage VC 02-Jul-2019 Completed Generating Revenue
4. Early Stage VC 26-Jun-2018 Completed Generating Revenue
3. Grant 01-Apr-2017 Completed Generating Revenue
2. Early Stage VC 15-Mar-2016 $1.1M $1.1M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2014 Completed Startup
To view Emosis’s complete valuation and funding history, request access »

Emosis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
To view Emosis’s complete cap table history, request access »

Emosis Patents

Emosis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018242607-A1 A rapid, on-demand heparin-induced thrombocytopenia functional assay Inactive 29-Mar-2017
CA-3057743-A1 A rapid, on-demand heparin-induced thrombocytopenia functional assay Pending 29-Mar-2017
EP-3602070-A1 A rapid, on-demand heparin-induced thrombocytopenia functional assay Active 29-Mar-2017
EP-3602070-B1 A rapid, on-demand heparin-induced thrombocytopenia functional assay Active 29-Mar-2017
ES-2924187-T3 A rapid, on-demand heparin-induced thrombocytopenia functional assay Active 29-Mar-2017 G01N33/6893
To view Emosis’s complete patent history, request access »

Emosis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emosis FAQs

  • When was Emosis founded?

    Emosis was founded in 2014.

  • Where is Emosis headquartered?

    Emosis is headquartered in Illkirch-Graffenstaden, France.

  • What is the size of Emosis?

    Emosis has 15 total employees.

  • What industry is Emosis in?

    Emosis’s primary industry is Diagnostic Equipment.

  • Is Emosis a private or public company?

    Emosis is a Private company.

  • What is Emosis’s current revenue?

    The current revenue for Emosis is .

  • How much funding has Emosis raised over time?

    Emosis has raised $4.51M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process